MarketPulse

neurological diseases

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nxera Pharma Hits $10M Milestone with AbbVie on Neurology Drug Discovery

Nxera Pharma receives $10M payment from AbbVie for identifying validated drug molecules against neurological disease target using proprietary platform.
ABBVpharmaceutical developmentcollaboration
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Serina Therapeutics to Showcase POZ Platform at Roth Conference

Clinical-stage biotech Serina Therapeutics will present at 38th Annual Roth Conference on March 24, 2026, highlighting its proprietary POZ Platform technology and pipeline.
PFESERclinical-stage biotechParkinson's disease